Considering the lack of comprehensive information focusing on the relationship between concurrent expression of putative CSC markers ALDH1 and CD133 with main clinicopathological factors in CRC, current study was aimed to evaluate the immunohistochemical expression of these markers in CRC patients. The gene discussed is PROM1; the disease is colorectal carcinoma.